A material used in plastic baby bottles and other products, which has been associated with such health risks as reproductive system abnormalities, prostate cancer, and obesity, could be banned this year, according to a professor at the University of Missouri, Columbia.
The timing of retirement has become a major topic of conversation as the recent stock market plunge decimated some retirement plans and individual portfolios.
As the Obama administration and the 111th Congress move forward on health care reform, increased sentiment for finding ways to support primary care physicians appears to be building. Unfortunately, urologists and other specialists could be asked to ante up.
A finely-tuned organization depends on being well-managed, and a urology practice is no exception.
One of the most effective strategies to protect assets is not to own them if you are an "at-risk" individual.
Today, a number of urologists are leaving their clinical practices to pursue entrepreneurial endeavors.
Data, data, data. It's the key discussion point in almost any article about health care reform.
Fertility clinics need more urologists, according to a study of male factor infertility information presented on fertility clinic web sites.
A recent prospective clinical trial found that the antidepressant paroxetine (Paxil) is associated with a five-fold increase in the risk of abnormal sperm DNA fragmentation as measured by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) score.
Researchers are developing promising new tools to improve the diagnosis of hypogonadism.
Men who turn to intracavernosal injection (ICI) therapy following prostate surgery can generate a satisfactory rigid erection with as few as five practice (trial) injections, according to studies presented at the 2008 Fall Scientific Meeting of the Sexual Medicine Society of North America.
I'm a member of a multi-specialty group, and we have about 18 to 20 days for vacation. I try to use it all because I do feel it's important to take time off.
Erectile dysfunction is a fact of life for many men who receive treatment for prostate cancer, but methods of measuring post-treatment ED and erectile function recovery suffer from a lack of standardization, according to studies presented at the Sexual Medicine Society of North America 2008 Fall Scientific Meeting.
Hypogonadism, or low serum testosterone, is associated with the unpleasant sequelæ of fatigue, low sex drive, diminished erections, and an increased tendency for fractures due to decreased bone mineral density.
AUA has named Christopher Saigal, MD, MPH, as its 2009-2010 Gallagher Health Policy Scholar.
Results of an interactive feature on the web site of the New England Journal of Medicine suggest a need for a large, rigorous, decisive head-to-head clinical trial comparing radiotherapy and surgery for the treatment of prostate cancer.
Bladder cancer is more likely to be fatal for women and African-Americans, but University of Rochester researchers report that factors traditionally cited for these higher mortality rates are responsible for only about one-third of the difference between white men and women and up to two-thirds of the difference between African-Americans and their white counterparts.
Donald F. Gleason, MD, PhD, 88, died of a heart attack Dec. 28 in Edina, MN. Dr. Gleason, who retired from the University of Minnesota Medical School in 1986, was a central figure in the development of the Gleason grading system for prostate cancer tumors.
AUA has released a best practice policy statement on the prevention of deep vein thrombosis (DVT) in patients undergoing urologic surgery.
AUA Practice Guidelines Committee Chair John B. Forrest, MD, discusses the committee's history, its work with other specialties, and its collaboration with international partners.
The U.S. Patent and Trademark Office issued patent numbers to cover Aureon Laboratories, Inc.?s systems and methods for evaluating the occurrence of any medical condition in a patient where clinical, imaging, and molecular data are combined and appraised.
Two drugs aimed at stemming bone loss in men with prostate cancer have moved closer to FDA approval.
Low-income men are more likely to present with advanced prostate cancers, most likely because they do not receive screening services shown to reduce the diagnosis of later-stage cancers, according to a study by UCLA researchers.
Ferring Pharmaceuticals, USA has received FDA approval to market degarelix, an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer.
Universal intraoperative cystoscopy following hysterectomy allows immediate repair of injuries to the ureter and bladder that would otherwise go undetected, according to a study published in Obstetrics & Gynecology (2009; 113:6-10).
Inderbir S. Gill, MD, has been appointed chair of the University of Southern California, Los Angeles Catherine and Joseph Aresty Department of Urology, effective Feb. 1.
In a new study that appears to refute earlier research, Massachusetts General Hospital researchers have found that treating prostate cancer patients with gonadotropin-releasing hormone (GnRH) agonists does not appear to increase the risk of death from cardiovascular disease.
Your interactive guide to ambulatory and surgical urology, practice management, and other physician topics available at modernmedicine.com.
What is an improper payment?
In the treatment of renal cell carcinoma, partial nephrectomy produces better quality of life than cryoablation, according to researchers at Washington University, St. Louis.